Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Conferences | Events

OGT to Host Cancer and Rare Disease Analysis Workshop at ESHG 2012

Customer and company experts to discuss identifying causative mutations using arrays and sequencing

 Oxford Gene Technology (OGT)Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, will host a workshop at this year's European Society of Human Genetics (ESHG) conference in Nürnberg, Germany (June 23-26). The session, entitled "Utilising arrays and next generation sequencing (NGS) to identify causative mutations in cancer and rare disease samples", will take place on Saturday 23rd June between 11:45 and 13.15 in the Istanbul Room, where lunch will be provided. It will feature presentations from international experts in array and sequencing-based cancer and rare disease research, including a talk by Professor Jacqueline Schoumans, head of the Cancer Cytogenetic Unit in Lausanne University Hospital, Switzerland. Professor Schoumans has recently worked with OGT to successfully develop and design a new array combining copy number and single nucleotide polymorphism (SNP) probes for investigating genomic variation in a wide range of haematological and solid cancers.

Also talking at the workshop will be Dr Dan Swan, a Senior NGS Computational Biologist at OGT, who will be discussing how OGT's Genefficiency Targeted Sequencing Service and bioinformatics expertise has allowed customers to successfully identify the genetic causes of cancer and rare disease. Utilising collaborative data, Dr Swan will provide a detailed review of OGT's NGS analysis pipeline, which allows the rapid interpretation of vast NGS datasets into meaningful results. Specific topics covered will include the analysis of paired tumour/normal samples, the detection of copy number variants and loss of heterozygosity mapping.

OGT will also host a booth at ESHG 2012 (number 234), where the company's experts will be on hand to discuss the needs of your cancer and rare disease studies. OGT offers a wide range of solutions, including its GenefficiencyTM Genomic Services for enabling high-throughput, high-quality array and targeted sequencing studies, as well as its CytoSureTM range of products and services for cytogeneticists.

For more details, or to register for the workshop, please visit

If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month


Today's Picks




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners